Introduction
Cystic fibrosis (CF)' is a lethal hereditary disorder caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a 250 kb, 27 exon gene on chromosome 7 (1) (2) (3) (4) . The CFTR gene product, a 168-kD glycosylated membrane protein, is thought to function as a chloride channel regulated by cytoplasmic protein kinases (3, (5) (6) (7) (8) (9) . Although the link between mutations in the CFTR gene and the pathogenesis of CF are not completely understood, the lethal clinical manifestations of CF are clearly related to the thick, infected mucus and chronic neutrophil-dominated inflammation on the epithelial surface ofthe airways (1, (10) (11) (12) (13) (14) . The large numbers of neutrophils place the airway epithelium in great jeopardy consequent to the exposure to potent neutrophil mediators, including neutrophil elastase, reactive oxygen species, and probably a variety ofcytokines (10) (11) (12) (13) (14) . Over time, this potent armamentarium overwhelms the local defense of the epithelium, resulting in damage and derangement of the airways (1, 13, (15) (16) (17) (18) (19) .
In this context, it is apparent that recruitment of neutrophils to the bronchial surface is a two-edged sword, necessary to contend with the local infection, but dangerous to the vulnerable epithelium. While it is not clear whether the numbers of neutrophils that are recruited are appropriate for the level of infection, in excess, or insufficient for host defense, it is relevant to ask the question: what signals the neutrophils to accumulate on the respiratory epithelial surface in CF? The answer is likely complex, and undoubtedly involves a variety ofmechanisms, including chemoattractants released by alveolar macrophages as well as those linked to the complement system (13, 14, (20) (21) (22) (23) (24) . The present study was designed to expand these concepts to include bronchial epithelial cells as a source of chemoattractants for neutrophils. Based on the knowledge that human bronchial epithelial cells can release the potent neutrophil chemoattractant IL-8 in response to a variety of stimuli (25) (26) (27) (28) , we hypothesized that the epithelial lining fluid (ELF) ofindividuals with CF contains signals capable ofinducing the expression of the IL-8 gene in bronchial epithelial cells. The data demonstrate that CF ELF does contain such signals, and interestingly, the dominant signal is neutrophil elastase (NE), suggesting a cycle of inflammation on the respiratory epithelium in CF, to where neutrophils are attracted and NE is released, resulting in induction ofexpression ofIL-8 by the respiratory epithelium, and the recruitment of more neutrophils.
Methods
Study population. The study population included eight individuals with cystic fibrosis (four male, four female; average age of 28±2 yr (all data are expressed as mean±standard error of the mean; all statistical comparisons were done with the two-tailed Student's t test]). All had a positive sweat chloride test, chronic sputum production, respiratory tract colonization with Pseudomonas aeruginosa, and moderate impairment oflung volumes and flow rates (as percentage predicted FEV, 41±4, FVC 52±5) (1, 29) . The average Shwachman score was 56±6 (30). All were lifelong nonsmokers. As a control, seven normal nonsmoking individuals were evaluated (four male, three female; average age of 29±3 yr). None had a history of pulmonary symptoms and all had normal physical examination, chest roentgenograms, and lung function tests.
Recovery ofrespiratory epithelial liningfluid. Bronchoalveolar lavage was used to obtain the respiratory ELF as previously described (31) . Cells were isolated from the fluid by centrifugation, and total and differential cell counts determined. ELF volumes were quantified by the urea method (32) . The fluid was maintained at -70°until evaluated.
Neutrophil elastase, neutrophil elastase inhibitors, and IL-8. NE activity in ELF was quantified using the NE-specific substrate methoxy-succinyl-alanyl-alanyl-prolyl-valyl-nitroanalide (Sigma Chemical Co., St. Louis, MO) as previously described (33) . Purified NE (Elastin Products Co., Inc., Pacific, MO) was titrated against a purified human al-antitrypsin (alAT) active standard (33) . Serine protease inhibitors used as inhibitors of NE in this study included human recombinant secretory leukoprotease inhibitor (SLPI; Synergen, Boulder, CO), human plasma aIAT (Calbiochem Corp., La Jolla, CA), PMSF (Calbiochem), and the NE-specific inhibitor methoxy-succinyl-alanyl-alanylprolyl-valyl-chloromethyl ketone (AAPV-CMK; Sigma). All inhibitors were tested in vitro for their activity in inhibiting NE as previously described (33 (35) . All studies were carried out when the cells were 80-90% confluent.
IL-8 mRNA transcript levels. The levels of IL-8 mRNA transcripts and control (3-actin mRNA transcripts were evaluated by Northern analysis and by slot blot hybridization (36, 37) . Total cellular RNA was isolated by the guanidinium thiocyanate-CsC1 gradient method (38) . For Northern analyses, RNA (10 ug/lane) was subjected to agarose gel electrophoresis and transferred to a nylon membrane (Nytran; Schleicher and Schuell Inc., Keene, NH). The filter was hybridized with probes labeled with 32P by the random priming method (39, 40). The IL-8 probe was a 750-bp cDNA derived from clone pPB248 containing the sequence from the PstI site of exon I to the BamHI site of exon IV (25) . It was constructed after reverse transcription of RNA from lipopolysaccharide (Escherichia coli 0127:B8; Difco Laboratories, Detroit, MI) stimulated human blood monocytes followed by amplification ofIL-8 cDNA using the polymerase chain reaction with IL-8 exon-specific oligonucleotide primers (NAFS 1, 5'-ATTTCTG-CAGCTCTGTGTGAAGGTGC-3'; and NAFAS2, 5'-TTGTGGAT-CCTGGCTAGCAGAC-3') (25, (41) (42) (43) . As a control ,B-actin probe, the cDNA clone pHF#A-I was used (44) . For normal and CF ELF studies and NE dose-dependence and time-course studies, mRNA transcript levels were quantified by slot blot hybridization analysis and densitometry (Ultroscan Laser Densitometer; Pharmacia LKB, Piscataway, NJ) using 10 Mg RNA as the starting material and the IL-8 and fl-actin probes described above.
Modulation ofIL-8 mRNA transcript levels. Based on prior observations that tumor necrosis factor-a (TNF) induced BET-lA cells to express the IL-8 gene (25) , human recombinant TNF (200 U/ml, 20 U/ng; Genzyme Corp., Boston, MA) was used as a positive control and prototype inflammatory stimulus. In parallel cultures, respiratory ELF (1 Ml ELF/ml culture media) from normals and individuals with CF were added to the cell culture, incubated for 3 h at 370, and IL-8 and f,-actin mRNA levels evaluated by Northern or slot blot analysis.
To determine the nature of the signals in CF ELF that induced BET-lA cells to express the IL-8 gene, the CF ELF was incubated for 10 min, 370 alone, or in the presence of the various protease inhibitors, including rSLPI (500 nM), a I AT (500 nM), PMSF (1 MM), or AAPV-CMK (1 WM). In parallel cultures, the mouse monoclonal anti-human TNF antibody (Genentech, Inc., South San Francisco, CA) was added. Based on the observation that the serine protease inhibitors prevented CF ELF from inducing IL-8 gene expression in the BET-lA cells, the studies were also carried out using purified NE alone or incubated with protease inhibitors in a similar fashion before their addition to the cell culture. The dose-dependent studies with NE were carried out using 0-50 nM ofpurified NE for 3 h. The time-course studies used 10 nM of NE and subsequent incubation of the BET-lA cells for 0-24 h. The dose and time-course studies were complicated by the effect of NE on detaching cells from the culture plate observed at concentrations ofNE > 50 nM or incubation with 10 nM for > 24 h, and these effects were limited to these conditions and times. Cell viability assessed by trypan blue dye exclusion was > 95% in all studies.
IL-8 release by neutrophil elastase-stimulated BET-IA cells. To demonstrate that NE induces bronchial epithelial cells to release functional IL-8, neutrophil chemotactic activity in the culture supernatants was evaluated from resting and NE-stimulated BET-lA cells as well as in ELF from individuals with CF and normal individuals using a modified Boyden chamber (45) . Neutrophils were isolated (> 95% pure) from blood of normal individuals by centrifugation through MonoPoly-Resolving medium (Flow Laboratories, Irvine, CA) (46) (Fig. 1, lane 1 (Fig. 2 A) . In contrast to the differences in IL-8 transcripts induced by normal and CF ELF, neither ELF changed f3-actin mRNA transcript levels (B).
Neutrophil elastase inhibitors prevent cysticfibrosis epithelial liningfluid induction ofIL-8 gene expression in bronchial epithelial cells. Based on the observations of increased numbers ofneutrophils in CF ELF, active NE in CF ELF was evaluated as a possible candidate for the signal that induced IL-8 gene expression in BET-i A cells.
First, NE inhibitors were evaluated for their ability to prevent CF ELF from inducing IL-8 gene expression in BET-lA cells (Fig. 3) (Fig. 4, lane I and 2 ). Further, (15, (59) (60) (61) . In addition, the presence oflarge numbers of neutrophils in CF ELF suggests that, in addition to NE, other neutrophil performed mediators such as myeloperoxidase, collagenase, gelatinase, and proteinase 3 may also be present (13, 50) . It is also possible that the bronchial epithelium may release chemoattractants other than IL-8 (62) (63) (64) (12) , but may also dampen the exaggerated recruitment of neutrophils to the lung in this disease. In this context, while caution must be used in not interfering with the necessity of neutrophils in the local host defense process, it is reasonable to suggest that anti-NE therapy, probably by direct aerosol administration, should be evaluated as a means oflimiting the neutrophil-dominated airway inflammation in this disorder.
